[1] |
Wu Minhang, Sun Wenzheng, Yu Qingzhuo, Guo Rong, Ye Hui, Du Ying, Qiu Jin, An Huazhang, Cao Lili.RNF43 inhibits PD-L1 expressionviaβ-catenin in melanoma cells and promotes CD8+T cell-mediated anti-tumor immune reaction[J]. Journal of International Oncology, 2023, 50(7): 407-412. |
[2] |
Li Bin, Zhang Guifang, Zhou Linjing, Yang Xiaodong, He Qiuli, Jia Sisi, Huang Puchao, Liang Jiaxin.Relationships between PIK3CA gene status and clinical features and prognosis in triple-negative breast cancer[J]. Journal of International Oncology, 2023, 50(5): 263-267. |
[3] |
Zhang Jingxian, Su Jianfei, Wei Xueqin, Yi Dan, Li Xiaojiang.Treatment status of non-small cell lung cancer with METexon14 skipping mutation[J]. Journal of International Oncology, 2023, 50(1): 37-41. |
[4] |
Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64. |
[5] |
Zhou Ye, Yu Yan.MET14 exon skipping mutation and non-small cell lung cancer[J]. Journal of International Oncology, 2021, 48(6): 366-369. |
[6] |
Zhang Ruizhi, Chen Xin, Zhang Peng, Tao Kaixiong.New progress on diagnosis and treatment of anorectal malignant melanoma[J]. Journal of International Oncology, 2020, 47(6): 377-380. |
[7] |
Du Mingli, Li Guixiang, Wu Wenjuan, Zhao Lei.Application of circulating tumor DNA in targeted therapy and immunotherapy of metastatic melanoma[J]. Journal of International Oncology, 2020, 47(6): 381-384. |
[8] |
Yi Zongbi, Ma Fei, Xu Binghe.Profile of gene mutations and targeted treatment of brain metastases in breast cancer[J]. Journal of International Oncology, 2019, 46(6): 354-357. |
[9] |
Wu Yuanyuan, Wang Jun.Advancement of targeted agents in the treatment of anaplastic thyroid carcinoma[J]. Journal of International Oncology, 2019, 46(2): 98-101. |
[10] |
Hu Wei, Zhang Yu.Analysis of gene detection status of EGFR mutation in 170 patients with advanced lung adenocarcinoma[J]. Journal of International Oncology, 2019, 46(1): 11-16. |
[11] |
Jin Lan, Kang Xiaojing.Drug resistance mechanism and treatment strategy for targeted therapy of melanoma[J]. Journal of International Oncology, 2018, 45(7): 444-448. |
[12] |
Li Lixi, Ma Fei.Clinicopathological characteristics and susceptibility genes of early-onset breast cancer[J]. Journal of International Oncology, 2018, 45(4): 241-244. |
[13] |
Miao Qiuju, Wang Yifei, Xu Xiulian..Molecular targeted therapy in malignant melanoma[J]. Journal of International Oncology, 2018, 45(11): 699-702. |
[14] |
Ma Yi, Xu Shun.Pulmonary adenocarcinoma shown as groundglass nodule: radiology, histopathology and molecular biology characteristics[J]. Journal of International Oncology, 2018, 45(10): 627-631. |
[15] |
Xia Dechun, Kang Xiaojing.Role and mechanism of Notch signaling pathway in melanoma growth and metastasis[J]. Journal of International Oncology, 2018, 45(10): 635-638. |